Modern management of renal cancer

Abstract

Although the prognosis for patients with metastatic kidney cancer is poor, those presenting with localised disease are potentially curable with nephrectomy alone. The authors explain how newer, targeted therapeutic agents show promise of extending survival, and outline recent advances in surgical options and the development of more precise prognostic indicators of disease progression and survival. Copyright © 2008 Wiley Interface Ltd